Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates

Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of$ 0.20 per share. This compares to loss of $1.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -85%. A quarter ago, it was expected that this company would post a loss of$ 0.52 per share when it actually produced earnings of $0.30, delivering a surprise of 157.69%.Over the last four quarters, the company h ...